Akinyi Ivy, Ouma Ogol Japheth, Ogutu Sylvester, Ogola Eric, Owenga Jane, Ayodo George, Omondi Dicken, Awandu Shehu Shagari, Vanden Broeck Davy, Redzic Nina, Pereira Ana Rita, Bogers Johannes
School of Health Sciences, Jaramogi Oginga Odinga University of Science and Technology, Bondo, Kenya.
AML, Sonic Healthcare, Antwerp.
Eur J Cancer Prev. 2025 Jul 1;34(4):329-336. doi: 10.1097/CEJ.0000000000000920. Epub 2024 Aug 29.
Human papillomavirus (HPV) coinfection remains common globally. However, its clinical significance compared to mono-infection remains controversial. Further, the epidemiology of HPV genotype combination in coinfection is not well studied in Kenya. . Between June and August 2023, a cross-sectional facility-based survey enrolled 434 women aged 16-68 years using purposive sampling strategy. Structured questionnaire was obtained from each woman regarding demographic and sexual behavior characteristics. Cervical specimen was collected from each participant and analyzed using RIATOL assay to determine HPV genotypes and viral load. Overall, HPV 52 was the most frequently detected HPV strain. The mean HPV viral load was elevated among coinfected women than those with mono-infection but there was no evidence to support differences in viral load in the two groups ( P = 0.113). Mono-infection was common (58.52%). HPV 16 was noted to have a near equal presence both in mono-infection and coinfection (52.17% and 47. 83%), respectively. HPV 33 (alpha 9) and 45 (alpha 7) had the greatest preference for each other compared to all other HPV interactions. HPV 52 is the most prevalent HPV in the population supporting the need for the nonavalent HPV vaccine. Mono-infection with HPV 16 remains common corroborating the relevance of bivalent vaccine in resource limited setting where nonavalent vaccines may be unavailable. The frequent coinfection preference of HPV 33 and 45 (alpha 9 and alpha 7, respectively) pauses the need for further concurrent characterization. HPV vaccination and education on safe sexual behaviors is key in reducing HPV coinfection.
人乳头瘤病毒(HPV)合并感染在全球范围内仍然很常见。然而,与单一感染相比,其临床意义仍存在争议。此外,肯尼亚对HPV基因型组合在合并感染中的流行病学研究不足。2023年6月至8月,一项基于机构的横断面调查采用立意抽样策略,纳入了434名年龄在16 - 68岁的女性。从每位女性那里获取了关于人口统计学和性行为特征的结构化问卷。从每位参与者收集宫颈样本,并使用RIATOL检测法进行分析,以确定HPV基因型和病毒载量。总体而言,HPV 52是最常检测到的HPV毒株。合并感染女性的平均HPV病毒载量高于单一感染女性,但没有证据支持两组病毒载量存在差异(P = 0.113)。单一感染很常见(58.52%)。HPV 16在单一感染和合并感染中的出现率几乎相等(分别为52.17%和47.83%)。与所有其他HPV相互作用相比,HPV 33(α9)和45(α7)彼此之间的偏好性最强。HPV 52是人群中最普遍的HPV,这支持了九价HPV疫苗的必要性。HPV 16单一感染仍然很常见,这证实了在可能无法获得九价疫苗的资源有限环境中,二价疫苗的相关性。HPV 33和45(分别为α9和α7)频繁的合并感染偏好表明需要进一步同时进行特征描述。HPV疫苗接种和安全性行为教育是减少HPV合并感染的关键。